Chutes and ladders on the critical path:comparative effectiveness, product value, and the use of biomarkers in drug development.
Woodcock
J
J
D000818:Animals; D015415:Biomarkers / Q000032:analysis*; D019091:Critical Pathways / Q000639:trends*; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods / Q000639:trends*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration / Q000639:trends
D015415:Biomarkers